FIGS (FIGS) 47th Annual Raymond James Institutional Investor Conference summary
Event summary combining transcript, slides, and related documents.
47th Annual Raymond James Institutional Investor Conference summary
12 May, 2026Business overview and industry positioning
Focuses on premium, functional products for healthcare professionals, transforming a traditionally unbranded, commoditized industry into a branded, community-driven space.
Serves a replenishment-driven, non-seasonal, and non-cyclical market with 2.9 million active customers out of 140 million global healthcare professionals.
Expanded from a digital-first model to an omni-channel presence, including five Community Hubs in major U.S. cities, with plans to open four more in 2026.
Maintains a low SKU count with high volume, minimizing fashion and inventory risk while driving repeat purchases.
Product innovation and marketing
Proprietary FIONx and new FORMx fabrications offer technical, durable, and comfortable apparel for various healthcare environments.
Expanded product categories include patented medical-grade compression socks, bags, and accessories, supporting broad-based growth.
Viral marketing campaigns, such as outfitting Team USA’s medical team and celebrity collaborations, have significantly increased brand engagement and organic traffic.
Top-of-funnel storytelling and performance-based marketing drive customer acquisition and retention, with marketing spend around 15% of sales.
Global expansion and growth strategy
Operates in 59 countries, focusing on deepening presence in Canada, Mexico, U.K., and Australia, while planning to enter 20 new markets in 2026.
Utilizes data-driven market entry and a global ambassador program with 600 influencers to drive word-of-mouth growth.
International sales grew 55% in the latest quarter, with China showing rapid traction on Tmall.
Latest events from FIGS
- Net revenues up 28% year-over-year, with record active customers and raised 2026 outlook.FIGS
Q1 202611 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.FIGS
Proxy filing23 Apr 2026 - Virtual meeting to vote on directors, auditor, and executive pay amid strong results and ESG focus.FIGS
Proxy filing23 Apr 2026 - Record 2025 revenue and margin gains, with 2026 outlook strong despite new global tariffs.FIGS
Q4 20257 Apr 2026 - Product innovation, global expansion, and new partnerships drive growth amid strong financials.FIGS
Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference3 Feb 2026 - All director, auditor, and executive compensation proposals were approved at the virtual meeting.FIGS
AGM 20241 Feb 2026 - Q2 revenue up 4.4%, margins down, $50M buyback, and flat-to-2% FY24 growth outlook.FIGS
Q2 20241 Feb 2026 - Data-driven innovation, advocacy, and omnichannel growth fuel expansion toward $1B sales.FIGS
TD Cowen’s 8th Annual Future of the Consumer Conference31 Jan 2026 - Strong repeat sales, innovation, and omni-channel growth drive margin recovery and expansion.FIGS
Goldman Sachs 31st Annual Global Retailing Conference22 Jan 2026